It is certainly interesting news although I don't think it suggests the best result. I fear the long-term consequence of Schedule II listing could be the creation of conditions where only large corporations will be able to survive the costs of FDA compliance.

Think about it.

Every formulation will need FDA approval and every medical claim will have to be clinically proven, that is very expensive to do. Big Pharma, anyone?

Each batch will have to be tested and blended to meet very precise content requirements. Can these requirements be met outside pill/capsule form? Oils and tinctures may be able to meet such standards but what about whole plant juicers? How can their needs be met under FDA control?

What happens to home-grow under FDA control? You can't grow opium poppies because opiates are Schedule II drugs so it is highly unlikely cannabis home-grow will be Federally-permitted under an S2 listing.

I'd love people to allay my fears so please, feel free to contradict me. I'd love to hear from you here.

Meanwhile, keep investing in smiles, the rewards are awesome!